La sua selezione è vuoto.
Definisci una selezione di ETF che ti piacerebbe confrontare.
Aggiungi un ETF selezionandolo dalla ricerca ETF o cliccando "Confronta" nella pagina di profilo dell'ETF.
| Index | ECPI Global ESG Medical Tech |
| Investment focus | Azioni, Globale, Salute, Sociali/Ambientali |
| Fund size | EUR 2 m |
| Total expense ratio | 0,31% annuo |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Si |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 13,52% |
| Inception/ Listing Date | 10 dicembre 2021 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Lussemburgo |
| Fund Provider | BNP Paribas Easy |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | BNP PARIBAS SECURITIES SERVICES-LUXEMBOURG BRANCH |
| Investment Advisor | |
| Custodian Bank | BNP PARIBAS, Luxembourg Branch |
| Revision Company | PricewaterhouseCoopers Société Coopérative |
| Fiscal Year End | 20 maggio |
| Swiss representative | BNP Paribas, Paris, Zurich Branch. |
| Swiss paying agent | BNP PARIBAS, Paris, Zurich Branch |
| Germany | 30% di rimborso fiscale |
| Switzerland | Dichiara all’ESTV |
| Austria | Dichiara tasse |
| UK | Non dichiara nel Regno Unito |
| Italy | - |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| argenx | 2,71% |
| Alnylam Pharmaceuticals | 2,71% |
| IQVIA Holdings | 2,57% |
| Genmab A/S | 2,52% |
| Thermo Fisher Scientific, Inc. | 2,48% |
| EssilorLuxottica SA | 2,46% |
| HOYA Corp. | 2,42% |
| BeOne Medicines | 2,33% |
| Smith & Nephew plc | 2,27% |
| Agilent Technologies | 2,27% |
| Salute | 91,65% |
| Beni voluttuari | 2,46% |
| Altri | 5,89% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0,00 € | 0,00 € | Scopri il broker* | |
| | 2,95 € 2,95% | 0,00 € | Scopri il broker* |
| YTD | +0.69% |
| 1 month | +2.58% |
| 3 months | +3.55% |
| 6 months | +8.17% |
| 1 year | -2.78% |
| 3 years | +1.27% |
| 5 years | - |
| Since inception (MAX) | -12.60% |
| 2025 | +3.21% |
| 2024 | +1.69% |
| 2023 | -17.87% |
| 2022 | - |
| Volatility 1 year | 13.52% |
| Volatility 3 years | 12.51% |
| Volatility 5 years | - |
| Return per risk 1 year | -0.21 |
| Return per risk 3 years | 0.03 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -19.57% |
| Maximum drawdown 3 years | -19.57% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -26.34% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | ASRP | - - | - - | - |
| Euronext Paris | EUR | MEDTE | MEDTE FP IMEDT | MEDTE.PA MEDTEINAV=IHSM | BNP aribas Arbitrage |
| SIX Swiss Exchange | EUR | MEDTE | MEDTE SW IMEDT | MEDTE.S MEDTEINAV=IHSM | BNP aribas Arbitrage |
| XETRA | EUR | ASRP | ASRP GY IMEDT | ASRP.DE MEDTEINAV=IHSM | BNP aribas Arbitrage |
| Nome del Fondo | Dimensione del fondo in milioni di € (valore di mercato) | TER p.a. | Distribuzione | Replica |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 1.045 | 0,40% p.a. | Accumulazione | Campionamento |
| iShares Ageing Population UCITS ETF | 800 | 0,40% p.a. | Accumulazione | Campionamento |
| Amundi S&P Global Health Care ESG UCITS ETF DR EUR (A) | 726 | 0,18% p.a. | Accumulazione | Replica totale |
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) | 560 | 0,18% p.a. | Distribuzione | Replica totale |
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Acc) | 297 | 0,18% p.a. | Accumulazione | Replica totale |